Gamma-linolenic acid provides additional protection against ventricular fibrillation in aged rats fed linoleic acid rich diets

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 62, Issue 2, 2000, Pages 129-134

  Charnock, J S ^a  

^a Charnock and Associates   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; BORAGE OIL; EDIBLE OIL; GAMMA LINOLENIC ACID; ICOSANOID; LINOLEIC ACID; PRIMROSE OIL; PROSTAGLANDIN SYNTHASE; SATURATED FATTY ACID; SUNFLOWER OIL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DISEASE SEVERITY; ENZYME ACTIVITY; FAT INTAKE; FATTY ACID METABOLISM; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; MALE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALIA; BORAGINACEAE; HELIANTHUS; OENOTHERA; PRIMULA;

EID: 0033995825     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1054/plef.1999.0132     Document Type: Article

References (49)

1. Shaper A. G. Coronary Heart Disease: Risks and Reasons. 1989;Current Medical Literature Ltd. London.
2. Lown B. Cardiovascular collapse and suddun cardiac death. Braunwald E. Heart Disease Vol 1. 1980;778-817 W. B. Saunders, Philadephia.
3. Myerburg R. J., Castellanos A. Cardiac arrest and sudden cardiac death. Braunwald E. Heart Disease Vol 1. 1980;742-777 W. B. Saunders, Philadephia.
4. Myerburg R. J. Epidemiology of ventricular tachycardia/ventricular fibrillation and sudden cardiac death. PACE. 1986;1334-1338.
5. Gillum R. F., Folson A. R., Blackburn H. Decline in coronary heart disease mortality: old questions and new facts. Am J Med. 76:1984;1055-1065.
6. Hetzel B. S., Charnock J. S., Dwyer T., McLennan P. L. Fall in coronary heart disease mortality in USA and Australia due to sudden death: Evidence for the role of polyunsaturated fat. J Clin Epidemiol. 42:1989;885-893.
7. The American Heart Association: Heart and stroke facts: 1995 statistical supplements. 1995.
8. Pye M. P., Cobb S. M. Mechanism of ventricular arrhythmia in cardiac failure and hypertrophy. Cardiovasc Res. 26:1992;740-750.
9. Al-Roomi K. A., Dobson A. J., Hall E., Heller R. F., Magnus P. Declining mortality from ischemic heart disease and cerebrovascular disease in Austalia. Am J Epidemiol. 129:1989;503-510.
10. Wellens H. J. J., Lemery R., Smeets J. L., Brugada P., Gorgels M. D., Cheriex E. C., deZwann C. Circulation. 85:1992;192-197.
11. Keefe D. L., Schwartz J., Somberg J. C. The substrate and the trigger: The role of myocardial vulnerability in sudden cardiac death. Am Heart J. 113:1987;218-225.
12. Charnock J. S. Lipids and cardiac arrhythmia. Prog Lipid Res. 33:1994;335-385.
13. Lepran I., Nemecz G. Y., Koltai M., Szekeres L. Effect of a linoleic acid rich diet on the acute phase of coronary occlusion in conscious rate: Influence of indomethacin and aspirin. J Cardiovasc Pharmacol. 3:1981;847-853.
14. 2αcontribute to the early consequences of acute myocardial ischaemia? J Mol Cell Cardiol. 13:1981;425-434.
15. Billman G. E., Hallaq H., Leaf A. Prevention of ischaemia- induced ventricular fibrillation by omega-3 fatty acids. Proc. Natl Acad. Sci: USA. 91:1994;4427-4430.
16. Isensee H., Jacob R. Differential effects of various oil diets on the risk of cardiac arrhythmias in rats. J Cardiovasc Risk. 1:1994;353-359.
17. Johnston K. M., MacLeod B. A., Walker M. J. A. Effects of aspirin and prostacyclin on arrhythmias resulting from coronary artery ligation and on infarct size. Brit J Pharmac. 78:1983;29-37.
18. Marshall R. J., Muir A. W., Winslow E. Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaethetized rat. Brit J Pharmacol. 78:1983;165-171.
19. McLennan P. L., Abeywardena M. Y., Charnock J. S. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol. 63:1985;1411-1413.
20. McLennan P. L., Abeywardena M. Y., Charnock J. S. The influence of age and dietary fat in an animal model of sudden cardiac death. Aust NZ J Med. 19:1989;1-5.
21. Charnock J. S., McLennan P. L., Sundram K., Abeywardena M. Y. Omega-3 PUFA's reduce the vulnerability of the rat heart to ischaemic arrhythmia in the presence of a high intake of saturated animal fat. Nutrit Res. 11:1991;1025-1034.
22. Lepran I., Szekeres L. Effect of dietary sunflower seed oil on the severity of reperfusion induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol. 19:1992;40-44.
23. Charnock J. S., Sundram K., Abeywardena M. Y., McLennan P. L., Tan D. T. Dietary fats and oils in cardiac arrhythmia in rats. Am J Clin Nutr. 53:1991;1047S-1049S.
24. McLennan P. L., Abeywardena M. Y., Charnock J. S. A comparison of the long-term effects of n-3 and n-6 polyunsaturated dietary supplements and the action of indomethacin upon the mechanical performances and susceptibility of the rat heart to dysrhythmia. Prost Leuk Med. 27:1987;183-195.
25. Parratt J. R., Coker S. J. Arachidonic acid cascade and the generation of ischemia and reperfusion induced ventricular arrhythmias. J Cardiovasc Pharmacol. 7:1985;S65-S70.
26. Horrobin D. F. Nutritional and medical importance of gamma- linolenic acid. Prog Lipid Res. 31:1992;161-194.
27. Darcet P., Driss F., Mendy F., Delhaye N. Effects of a diet enriched with gamma-linolenic acid on PUFA metabolism and platelet aggregation in elderly men. Ann Nutr. 34:1980;277-290.
28. Peluffo R. O., Ayala S., Brenner R. R. Metabolism of fatty acids in the linoleic acid series in testicles in rats. Am J Physiol. 218:1970;669-673.
29. Biagi P. L., Bordini A., Hrelia S., Celadon M., Horrobin D. F. γ-linolenic acid dietary supplementation can reverse the ageing influence on rat. Liver -6 desaturase activity. Biochem Biophys Acta. 1083:1991;187-192.
30. Dinh T. K. L., Bourre J. M., Durrand G. Effect of age and α-linolenic acid deficiency on -6 desaturase activity and liver lipids in rats. Lipids. 28:1993;517-523.
31. Horrobin D. F., Manku M. S. Clinical biochemistry of essential fatty acids. Horrobin D. F. Omega-6 essential fatty acids: Pathophysiology and roles in clinical medicine. 1990;21-53 Alan R Liss, New York.
32. Sinclair H. M. Supply and dietary use of fats. Lancet. i:1959;474-475.
33. Charnock J. S., Abeywardena M. Y., McLennan P. L. Comparative changes in the fatty acid composition of rat cardiac phospholipids after long term feeding of sunflower seed oil or tuna fish oil supplemented diets. Ann Nutr Metab. 30:1986;393-400.
34. Abeywardena M. Y., McLennan P. L., Charnock J. S. Long term saturated fat feeding induced changes in rat myocardial phospholipid fatty acids are reversed by cross-over to polyunsaturated diets: Differences between omega-3 and omega-6 lipid supplements. Nutr Res. 7:1987;743-754.
35. McLennan P. L., Abeywardena M. Y., Charnock J. S. Reversal of the arrhythmogenic effects of long-term saturated fatty acid intake by dietary n-3 and n-6 polyunsaturated fatty acids. Am J Clin Nutr. 51:1990;53-58.
36. Wallenstein S., Zucker C. L., Fleiss J. L. Some statistical methods useful in circulation research. Circ Res. 47:1980;1-9.
37. Charnock J. S., Crozier G. L., Woodhouse J. Gamma-linolenic acid, black currant seed oil and evening primrose oil in the prevention of cardiac arrhythmia in aged rats. Nutr Res. 14:1994;1089-1099.
38. Charnock J. S., Bridle T. M., Turner P. L., McLennan P. L., Abeywardena M. Y. Vitamin E and health in the marmoset monkey: A non-human primate model for nutritional research. Ong ASH, Packer L. Lipid soluble antioxidants: Biochemistry and clinical applications. 1992;134-151 Birkhaüer Verlag, Basel, Switzerland.
39. McLennan P. L. Relative effects of dietary saturated, monounsaturated and polyunsaturated fatty acids on cardiac arrhythmia in rats. Am J Clin Nutr. 57:1993;207-212.
40. Manning A. S., Hearse D. J. Reperfusion induced arrhythmias: mechanism and prevention. J Mol Cell Cardiol. 16:1984;497-518.
41. Engler M. M. Comparative study of diets enriched with evening primrose, blackcurrant, borage or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins, Leukotrienes and Essential Fatty Acids. 49:1993;809-814.
42. Cotter M. A., Dines K. C., Cameron N. E. Omega-6 essential fatty acid dysymetabolism and γ-linolenic acid in experimental diabetic neuropathy. Hoffa N, Greene D A, Ward J D., Sima A AF, Boulton A JM. Diabetic neuropathy: New concepts and insights. 1995;257-262 Elsevier Science BV.
43. Horrobin D. F. Gamma-linolenic acid: An intermediate in essential fatty acid metabolism with potential as an ethical pharmaceutical and as a food. Rev Contemp Pharmacother. 1:1990;1-45.
44. 1synthesis is altered by dietary gamma- linolenic acid. J Nutr. 122:1992;1600-1606.
45. Abeywardena M. Y., McLennan P. L., Charnock J. S. Differences between in vivo and in vitro production of eicosanoids following long term dietary fish oil supplementation in the rat. Prostaglandins, Leukotrienes and Essential Fatty Acids. 42:1991;159-165.
46. Coker S. J., Parratt J. R., Ledingham Mc.A., Zeitlen I. J. Evidence that thromboxane contributes to ventricular fibrillation induced by reperfusion of the ischaemic myocardium. J Mol Cell Cardiol. 14:1982;483-486.
47. Charnock J. S., McLennan P. L., Abeywardena M. Y. Dietary modulation of lipid metabolism and mechanical performance of the heart. Mol Cell Biochem. 116:1992;19-25.
48. 2production. Am J Physiol. 29:1991;H379-H385.
49. Charnock J. S. Dietary fats and cardiac arrhythmia in primates. Nutrition. 10:1994;161-169.